menu
Forecasting 2022-2028: Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market trends, share, size, growth, opportunities, and forecasts
Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market

When your pancreas fails to produce enough digestive enzymes, EPI develops. The enzymes don't always function as they should.

Proteins called enzymes are responsible for chemical processes in your body. Digestive enzymes help your body absorb nutrients by breaking down meals. Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market is more common in people with chronic pancreatitis and children with cystic fibrosis.

EPI in adults is most commonly brought on by chronic pancreatitis. Up to 80% of adults with this disease will eventually get EPI. The pancreas becomes inflamed and swollen as a result of pancreatitis. The pancreatic cells that produce digestive enzymes may eventually become damaged by persistent inflammation.

 

Read More @ https://cmiinfonest.blogspot.com/2023/03/exocrine-pancreatic-insufficiency-epi.html